← 產業報告目錄

Pharmaceutical Metal Detector Market by Product (Tablet, Capsule, Powder, Liquid Detectors), Technology (Magnetic Field, Multi-frequency Detector, X-ray Inspection with Metal Detectors), and Application (Packaging Detection, QC) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-07-31頁數 247報告編號 PH9443

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global pharmaceutical metal detectors market is projected to reach USD 197.7 million by 2030 from USD 157.1 million in 2025, registering a CAGR of 4.7% during the forecast period. The growth is primarily driven by stringent regulatory requirements for product safety and the rising demand for contamination-free pharmaceutical products. Increasing cases of product recalls and quality-related concerns have compelled manufacturers to adopt advanced detection technologies. The growing integration of automated and intelligent metal detection systems, coupled with innovations in sensor sensitivity and real-time monitoring, is further expected to boost market expansion. Emphasis on compliance with GMP and FDA standards also encourages pharmaceutical companies to invest in high-precision inspection equipment. Moreover, industry players are increasingly engaging in product innovation and strategic collaborations to enhance their competitive edge and ensure process reliability. By product type, the tablet metal detectors segment accounted for the largest market share in 2024. Tablet metal detectors dominated the pharmaceutical metal detectors market in 2024, primarily due to the widespread production of tablets across the global pharmaceutical industry. Tablets remain the most preferred and commonly manufactured solid dosage form because of their convenience, long shelf life, and patient compliance. The ease of integration, cost-efficiency, and reliability of tablet metal detectors have led to their wide adoption by both large pharmaceutical manufacturers and contract manufacturing organizations (CMOs). With rising global drug demand and tighter quality controls, the use of tablet metal detectors continues to expand, solidifying their position as the leading product type in this market. By technology, the magnetic field detectors segment accounted for the largest share of the market in 2024. Magnetic field detectors held the largest share of the pharmaceutical metal detectors market in 2024 due to their proven effectiveness, cost-efficiency, and adaptability across various pharmaceutical applications. Magnetic field detectors require less capital than more advanced systems like X-ray or multi-frequency detectors. For many pharmaceutical manufacturers, especially those operating in cost-sensitive or emerging markets, this affordability, paired with performance, makes magnetic field technology the preferred choice. Altogether, their combination of precision, versatility, and economic value solidifies their dominance in the pharmaceutical metal detectors market. By region, North America is expected to witness the highest growth rate during the forecast period. The key factors driving market growth in North America include a high level of technological adoption and automation in pharmaceutical manufacturing facilities. This environment supports the integration of advanced metal detection systems that feature real-time data tracking, AI-based calibration, and automated rejection systems. Higher R&D spending and early adoption of Industry 4.0 practices have driven the use of multi-frequency and magnetic field detectors across North American facilities. This focus on innovation and operational efficiency further boosts the regional demand. The increasing number of drug recalls due to contamination risks and the growing export volume of US- and Canada-manufactured pharmaceutical products also necessitate robust inspection protocols, further reinforcing the dominance of North America in the pharmaceutical metal detectors market. Breakdown of supply-side primary interviews: • By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%) • By Designation: C-level Executives (35%), Directors (25%), and Others (40%) • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%) Breakdown of demand-side primary interviews: • By Company Type: Pharmaceutical Companies (50%), CDMOs (25%), Biopharmaceutical Companies (15%), and Other End Users (10%) • By Designation: Heads of Manufacturing/Production (40%), Quality Assurance Managers (30%), Regulatory Compliance Officers (20%), and Other Designations (10%) • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%) Research Coverage This report studies the pharmaceutical metal detectors market by product, technology, application, end user, and region. The report also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Additionally, the report examines micromarkets concerning their growth trends and predicts the revenue of the market segments across four key regions and their respective countries. Reasons to Buy the Report The report can assist both established and smaller firms in assessing the market, which would enable them to capture a larger share. Companies that purchase the report could utilize one or a combination of the five strategies outlined below. This report provides insights into the following pointers: • Analysis of key drivers (growing number of product recalls due to metal contamination, stringent regulatory compliance mandates by regulatory authorities, and growing adoption of automation and inline quality control systems), restraints (high initial capital expenditure and recurring maintenance costs and operational challenges in detecting non-ferrous and foil-based contaminants), opportunities (focus on production optimization and high R&D investments and expansion of pharmaceutical exports and contract manufacturing), and challenges (integration complexity with existing production lines) are expected to influence the growth of the pharmaceutical metal detectors market. • Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and product launches in the pharmaceutical metal detectors market. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for several types of pharmaceutical metal detection processes across regions. • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the pharmaceutical metal detectors market. • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the pharmaceutical metal detectors market.
目錄 Table of Contents
1 INTRODUCTION 23 1.1 STUDY OBJECTIVES 23 1.2 MARKET DEFINITION 24 1.3 STUDY SCOPE 24 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 24 1.3.2 INCLUSIONS & EXCLUSIONS 25 1.3.3 YEARS CONSIDERED 25 1.4 CURRENCY 26 1.5 STAKEHOLDERS 26 2 RESEARCH METHODOLOGY 28 2.1 RESEARCH APPROACH 28 2.1.1 SECONDARY DATA 29 2.1.2 PRIMARY DATA 31 2.2 MARKET SIZE ESTIMATION 34 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 40 2.4 MARKET SHARE ESTIMATION 41 2.5 STUDY ASSUMPTIONS 41 2.6 RISK ASSESSMENT 42 2.7 RESEARCH LIMITATIONS 42 2.7.1 METHODOLOGY-RELATED LIMITATIONS 42 2.7.2 SCOPE-RELATED LIMITATIONS 42 3 EXECUTIVE SUMMARY 43 4 PREMIUM INSIGHTS 47 4.1 PHARMACEUTICAL METAL DETECTORS MARKET OVERVIEW 47 4.2 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET OVERVIEW 48 4.3 PHARMACEUTICAL METAL DETECTORS MARKET: REGIONAL MIX 49 4.4 PHARMACEUTICAL METAL DETECTORS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 50 4.5 PHARMACEUTICAL METAL DETECTORS MARKET: DEVELOPING VS. DEVELOPED ECONOMIES 51 5 MARKET OVERVIEW 52 5.1 INTRODUCTION 52 5.2 MARKET DYNAMICS 53 5.2.1 DRIVERS 53 5.2.1.1 Growing number of product recalls due to metal contamination 53 5.2.1.2 Stringent regulatory compliance mandates 54 5.2.1.3 Growing adoption of automation and inline quality control systems 54 5.2.2 RESTRAINTS 55 5.2.2.1 High initial capital expenditure and recurring maintenance costs 55 5.2.2.2 Operational challenges in detecting non-ferrous and foil-based contaminants 56 5.2.3 OPPORTUNITIES 56 5.2.3.1 Focus on production optimization and high R&D investment 56 5.2.3.2 Expansion of pharmaceutical exports and contract manufacturing 57 5.2.4 CHALLENGES 57 5.2.4.1 Integration complexity with existing production lines 57 5.3 TECHNOLOGY ANALYSIS 58 5.3.1 KEY TECHNOLOGIES 58 5.3.1.1 Electromagnetic induction technology 58 5.3.1.2 Multi frequency detection 58 5.3.2 COMPLEMENTARY TECHNOLOGIES 58 5.3.2.1 Conveyor and reject mechanism systems 59 5.3.2.2 Human–machine interface (HMI) and touchscreen controls 59 5.4 PORTER’S FIVE FORCES ANALYSIS 59 5.4.1 INTENSITY OF COMPETITIVE RIVALRY 60 5.4.2 BARGAINING POWER OF BUYERS 61 5.4.3 BARGAINING POWER OF SUPPLIERS 61 5.4.4 THREAT OF SUBSTITUTES 61 5.4.5 THREAT OF NEW ENTRANTS 61 5.5 REGULATORY ANALYSIS 62 5.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 5.5.2 REGULATORY FRAMEWORK 66 5.5.2.1 North America 66 5.5.2.1.1 US 66 5.5.2.1.2 Canada 66 5.5.2.2 Europe 66 5.5.2.2.1 Germany 66 5.5.2.3 Asia Pacific 67 5.5.2.3.1 China 67 5.5.2.3.2 Japan 67 5.5.2.3.3 India 67 5.5.2.3.4 Australia 67 5.5.2.4 Rest of the World 67   5.6 PATENT ANALYSIS 67 5.6.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS, AND JURISDICTION FOR PHARMACEUTICAL METAL DETECTORS MARKET, JANUARY 2015–MAY 2025 68 5.6.2 LIST OF MAJOR PATENTS, 2023–2024 70 5.7 TRADE ANALYSIS 71 5.7.1 IMPORT DATA FOR HS CODE 854370, 2020–2024 71 5.7.2 EXPORT DATA FOR HS CODE 854370, 2020–2024 72 5.8 KEY CONFERENCES & EVENTS, 2025–2026 73 5.9 KEY STAKEHOLDERS & BUYING CRITERIA 73 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 74 5.9.2 KEY BUYING CRITERIA 74 5.10 PRICING ANALYSIS 75 5.10.1 INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY PRODUCT TYPE, 2022–2024 75 5.10.2 INDICATIVE PRICING ANALYSIS OF PHARMACEUTICAL METAL DETECTORS, BY REGION, 2022–2024 77 5.11 VALUE CHAIN ANALYSIS 78 5.12 ECOSYSTEM ANALYSIS 79 5.13 IMPACT OF AI/GEN AI ON PHARMACEUTICAL METAL DETECTORS MARKET 80 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80 5.15 INVESTMENT & FUNDING SCENARIO 81 5.16 IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL METAL DETECTORS MARKET 82 5.16.1 INTRODUCTION 82 5.16.2 KEY TARIFF RATES 82 5.16.3 PRICE IMPACT ANALYSIS 83 5.16.4 IMPACT ON COUNTRY/REGION 83 5.16.4.1 US 83 5.16.4.2 Europe 84 5.16.4.3 APAC 84 5.16.5 IMPACT ON END-USE INDUSTRIES 84 5.16.5.1 Pharmaceutical companies 84 5.16.5.2 Contract Development and Manufacturing Organizations (CDMOs) 85 5.16.5.3 Other end users 85 6 PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT 86 6.1 INTRODUCTION 87 6.2 TABLET METAL DETECTORS 87 6.2.1 TABLET METAL DETECTORS TO DOMINATE MARKET DUE TO HIGH DEPLOYMENT IN LINE WITH TABLET PRESSES 87 6.3 CAPSULE METAL DETECTORS 89 6.3.1 INCREASING NEED FOR PRECISION DURING CAPSULE FILLING AND PACKAGING TO BOOST ADOPTION 89   6.4 POWDER METAL DETECTORS 90 6.4.1 HIGH RISK OF CONTAMINATION IN DRY BULK PROCESSING TO DRIVE ADOPTION OF POWDER METAL DETECTORS 90 6.5 LIQUID METAL DETECTORS 92 6.5.1 INCREASING USE IN SYRUPS AND SUSPENSIONS REQUIRING BATCH PURITY TO SUPPORT MARKET GROWTH 92 6.6 PIPELINE METAL DETECTORS 94 6.6.1 GROWING POPULARITY DUE TO EFFICIENCY IN CONTINUOUS FLOW SYSTEMS FOR SEMI-SOLIDS AND LIQUIDS TO FUEL MARKET GROWTH 94 7 PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY 96 7.1 INTRODUCTION 97 7.2 MAGNETIC FIELD DETECTORS 97 7.2.1 VERSATILITY OF MAGNETIC FIELD DETECTORS ACROSS VARIOUS PRODUCT TYPES AND PACKAGING FORMATS TO BOOST ADOPTION 97 7.3 MULTI-FREQUENCY DETECTORS 99 7.3.1 NEED FOR HIGH SENSITIVITY IN MIXED PRODUCT LINES TO BOOST DEMAND FOR MULTI-FREQUENCY METAL DETECTORS 99 7.4 X-RAY INSPECTION WITH METAL DETECTORS 101 7.4.1 SUPERIOR PERFORMANCE IN DETECTING DENSE AND NON-METALLIC CONTAMINANTS TO SUPPORT MARKET GROWTH 101 7.5 OTHER TECHNOLOGIES 103 8 PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION 104 8.1 INTRODUCTION 105 8.2 QUALITY CONTROL 105 8.2.1 STRINGENT GMP GUIDELINES EMPHASIZING END-TO-END PRODUCT INSPECTION TO CONTRIBUTE TO MARKET GROWTH 105 8.3 CONTAMINANT DETECTION 106 8.3.1 GROWING PRODUCT RECALLS AND HEALTH RISKS TO BOOST GROWTH 106 8.4 PACKAGING 107 8.4.1 RISING USE OF INLINE DETECTORS IN HIGH-SPEED PRODUCTION LINES TO SUPPORT MARKET GROWTH 107 8.5 COMPLIANCE 108 8.5.1 TIGHTER GLOBAL REGULATIONS AND INCREASED AUDIT PREPAREDNESS TO DRIVE GROWTH IN MARKET 108 9 PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER 110 9.1 INTRODUCTION 111 9.2 PHARMACEUTICAL COMPANIES 111 9.2.1 HIGH VOLUME OF DRUG MANUFACTURING ACTIVITIES AND STRINGENT QA PROTOCOLS TO DRIVE GROWTH 111 9.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS) 112 9.3.1 STRONG OUTSOURCING DEMAND TO PROPEL CDMO SEGMENTAL GROWTH 112   9.4 BIOPHARMACEUTICAL COMPANIES 113 9.4.1 RAPID EXPANSION OF BIOLOGICS MANUFACTURING CAPACITY TO BOOST METAL DETECTOR USAGE IN BIOPHARMACEUTICAL FIRMS 113 9.5 OTHER END USERS 114 10 PHARMACEUTICAL METAL DETECTORS MARKET, BY REGION 116 10.1 INTRODUCTION 117 10.2 NORTH AMERICA 118 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 118 10.2.2 US 122 10.2.2.1 Stringent FDA enforcement and contamination recalls to propel metal detector demand in US 122 10.2.3 CANADA 125 10.2.3.1 National biomanufacturing strategy to spur metal detector integration in Canada 125 10.3 EUROPE 128 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 128 10.3.2 GERMANY 132 10.3.2.1 Robust R&D and manufacturing excellence to drive market 132 10.3.3 UK 135 10.3.3.1 Rising quality-driven inspection spending to boost market 135 10.3.4 FRANCE 138 10.3.4.1 Government-backed reshoring efforts and sterile drug production to propel demand for metal detectors in France 138 10.3.5 ITALY 140 10.3.5.1 Country's biopharmaceutical growth to support market uptake 140 10.3.6 SPAIN 143 10.3.6.1 Public-sector manufacturing expansion and generics uptake to boost metal detector demand 143 10.3.7 REST OF EUROPE 145 10.4 ASIA PACIFIC 148 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 148 10.4.2 CHINA 152 10.4.2.1 Booming biologics hubs to fuel market growth in China 152 10.4.3 JAPAN 155 10.4.3.1 Aging population and universal health coverage to drive adoption 155 10.4.4 INDIA 158 10.4.4.1 Surging compliance upgrades and massive export ambitions to drive adoption 158 10.4.5 AUSTRALIA 161 10.4.5.1 Advanced pharmaceutical manufacturing to drive quality-centric investments 161   10.4.6 SOUTH KOREA 164 10.4.6.1 Innovation-driven pharma sector to promote advanced quality assurance 164 10.4.7 REST OF ASIA PACIFIC 166 10.5 REST OF THE WORLD 168 10.5.1 MACROECONOMIC OUTLOOK FOR REST OF THE WORLD 169 11 COMPETITIVE LANDSCAPE 172 11.1 OVERVIEW 172 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 172 11.3 REVENUE ANALYSIS, 2022–2024 174 11.4 MARKET SHARE ANALYSIS, 2024 175 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 176 11.5.1 STARS 177 11.5.2 EMERGING LEADERS 177 11.5.3 PERVASIVE PLAYERS 177 11.5.4 PARTICIPANTS 177 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 179 11.5.5.1 Company footprint 179 11.5.5.2 Region footprint 180 11.5.5.3 Product footprint 181 11.5.5.4 Technology footprint 182 11.5.5.5 Application footprint 183 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 184 11.6.1 PROGRESSIVE COMPANIES 184 11.6.2 RESPONSIVE COMPANIES 184 11.6.3 DYNAMIC COMPANIES 184 11.6.4 STARTING BLOCKS 184 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 186 11.6.5.1 Detailed list of key startup/SME players 186 11.6.5.2 Competitive benchmarking of key emerging players/startups 187 11.7 BRAND/PRODUCT COMPARISON 188 11.8 R&D EXPENDITURE OF KEY PLAYERS 189 11.9 COMPANY VALUATION & FINANCIAL METRICS 189 11.9.1 FINANCIAL METRICS 189 11.9.2 COMPANY VALUATION 190 11.10 COMPETITIVE SCENARIO 190 11.10.1 PRODUCT LAUNCHES 191 11.10.2 DEALS 192 11.10.3 EXPANSIONS 192 11.10.4 OTHER DEVELOPMENTS 192   12 COMPANY PROFILES 193 12.1 KEY PLAYERS 193 12.1.1 METTLER-TOLEDO INTERNATIONAL INC. 193 12.1.1.1 Business overview 193 12.1.1.2 Products offered 194 12.1.1.3 MnM view 195 12.1.1.3.1 Right to win 195 12.1.1.3.2 Strategic choices 195 12.1.1.3.3 Weaknesses & competitive threats 196 12.1.2 THERMO FISHER SCIENTIFIC INC. 197 12.1.2.1 Business overview 197 12.1.2.2 Products offered 198 12.1.2.3 MnM view 199 12.1.2.3.1 Right to win 199 12.1.2.3.2 Strategic choices 199 12.1.2.3.3 Weaknesses & competitive threats 199 12.1.3 ANRITSU CORPORATION 200 12.1.3.1 Business overview 200 12.1.3.2 Products offered 201 12.1.3.3 Recent developments 202 12.1.3.3.1 Product launches 202 12.1.3.4 MnM view 202 12.1.3.4.1 Right to win 202 12.1.3.4.2 Strategic choices 203 12.1.3.4.3 Weaknesses & competitive threats 203 12.1.4 MINEBEAMITSUMI INC. 204 12.1.4.1 Business overview 204 12.1.4.2 Products offered 205 12.1.4.3 Recent developments 206 12.1.4.3.1 Product launches 206 12.1.5 ILLINOIS TOOL WORKS INC. 207 12.1.5.1 Business overview 207 12.1.5.2 Products offered 208 12.1.5.3 Recent developments 209 12.1.5.3.1 Product launches 209 12.1.6 ERIEZ MANUFACTURING CO. 210 12.1.6.1 Business overview 210 12.1.6.2 Products offered 210 12.1.6.3 Recent developments 211 12.1.6.3.1 Deals 211 12.1.6.3.2 Other developments 211   12.1.6.4 MnM view 211 12.1.6.4.1 Right to win 211 12.1.6.4.2 Strategic choices 211 12.1.6.4.3 Weaknesses & competitive threats 212 12.1.7 CEIA S.P.A. 213 12.1.7.1 Business overview 213 12.1.7.2 Products offered 213 12.1.7.3 Recent developments 214 12.1.7.3.1 Product launches 214 12.1.7.3.2 Expansions 215 12.1.7.4 MnM view 215 12.1.7.4.1 Right to win 215 12.1.7.4.2 Strategic choices 215 12.1.7.4.3 Weaknesses & competitive threats 215 12.1.8 FORTRESS TECHNOLOGY INC. 216 12.1.8.1 Business overview 216 12.1.8.2 Products offered 216 12.1.8.3 Recent developments 217 12.1.8.3.1 Product launches 217 12.1.8.3.2 Deals 217 12.1.9 CASSEL MESSTECHNIK GMBH 218 12.1.9.1 Business overview 218 12.1.9.2 Products offered 218 12.1.9.3 Recent developments 219 12.1.9.3.1 Product launches 219 12.1.10 BUNTING 220 12.1.10.1 Business overview 220 12.1.10.2 Products offered 220 12.1.11 NIKKA DENSOK LIMITED 221 12.1.11.1 Business overview 221 12.1.11.2 Products offered 221 12.1.12 PRISMA INDUSTRIALE S.R.L. 223 12.1.12.1 Business overview 223 12.1.12.2 Products offered 223 12.1.13 WIPOTEC GMBH 224 12.1.13.1 Business overview 224 12.1.13.2 Products offered 224 12.1.14 DONGGUAN COSO ELECTRONIC TECH CO., LTD. 225 12.1.14.1 Business overview 225 12.1.14.2 Products offered 225   12.1.15 VINSYST TECHNOLOGIES 226 12.1.15.1 Business overview 226 12.1.15.2 Products offered 226 12.2 OTHER PLAYERS 227 12.2.1 SED PHARMA 227 12.2.2 NEMESIS SRL 228 12.2.3 SOLLAU S.R.O. 229 12.2.4 TECHNOFOUR ELECTRONICS PVT. LTD. 230 12.2.5 INOS 231 12.2.6 ACG 232 12.2.7 ULTRACON ENGIMECH PVT. LTD. 233 12.2.8 DAS ELECTRONICS 234 12.2.9 UNIQUE EQUIPMENT 235 12.2.10 LODHA INTERNATIONAL LLP 236 13 APPENDIX 237 13.1 DISCUSSION GUIDE 237 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 243 13.3 CUSTOMIZATION OPTIONS 245 13.4 RELATED REPORTS 245 13.5 AUTHOR DETAILS 246
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD) 26 TABLE 2 PHARMACEUTICAL METAL DETECTORS MARKET: STUDY ASSUMPTION ANALYSIS 41 TABLE 3 PHARMACEUTICAL METAL DETECTORS MARKET: RISK ASSESSMENT ANALYSIS 42 TABLE 4 PHARMACEUTICAL METAL DETECTORS MARKET: PORTER’S FIVE FORCES 59 TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 8 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 10 IMPORT DATA FOR HS CODE 854370, BY COUNTRY, 2020–2024 (USD MILLION) 71 TABLE 11 EXPORT DATA FOR HS CODE 854370, BY COUNTRY, 2020–2024 (USD MILLION) 72 TABLE 12 PHARMACEUTICAL METAL DETECTORS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JULY 2025−JUNE 2026 73 TABLE 13 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 74 TABLE 14 KEY BUYING CRITERIA FOR PHARMACEUTICAL METAL DETECTORS, BY END USER 75 TABLE 15 INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY PRODUCT TYPE, 2022–2024 (USD) 76 TABLE 16 INDICATIVE PRICING ANALYSIS OF PHARMACEUTICAL METAL DETECTORS, BY REGION, 2022–2024 (USD) 77 TABLE 17 PHARMACEUTICAL METAL DETECTORS MARKET: IMPACT OF AI/GEN AI 80 TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES 82 TABLE 19 PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 87 TABLE 20 TABLET METAL DETECTORS AVAILABLE IN MARKET 88 TABLE 21 TABLET METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 88 TABLE 22 CAPSULE METAL DETECTORS AVAILABLE IN MARKET 89 TABLE 23 CAPSULE METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 90 TABLE 24 POWDER METAL DETECTORS AVAILABLE IN MARKET 91 TABLE 25 POWDER METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 26 LIQUID METAL DETECTORS AVAILABLE IN MARKET 93 TABLE 27 LIQUID METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 28 PIPELINE METAL DETECTORS AVAILABLE IN MARKET 94 TABLE 29 PIPELINE METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 30 PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 97 TABLE 31 MAGNETIC FIELD DETECTORS AVAILABLE IN MARKET 98 TABLE 32 MAGNETIC FIELD DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 33 MULTI-FREQUENCY DETECTORS AVAILABLE IN MARKET 100 TABLE 34 MULTI-FREQUENCY DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 35 X-RAY INSPECTION WITH METAL DETECTORS AVAILABLE IN MARKET 102 TABLE 36 X-RAY INSPECTION WITH METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 37 OTHER PHARMACEUTICAL METAL DETECTION TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 38 PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 105 TABLE 39 PHARMACEUTICAL METAL DETECTORS MARKET FOR QUALITY CONTROL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 40 PHARMACEUTICAL METAL DETECTORS MARKET FOR CONTAMINANT DETECTION APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 41 PHARMACEUTICAL METAL DETECTORS MARKET FOR PACKAGING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 42 PHARMACEUTICAL METAL DETECTORS MARKET FOR COMPLIANCE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 43 PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 111 TABLE 44 PHARMACEUTICAL METAL DETECTORS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 45 PHARMACEUTICAL METAL DETECTORS MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS), BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 46 PHARMACEUTICAL METAL DETECTORS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 47 PHARMACEUTICAL METAL DETECTORS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 48 PHARMACEUTICAL METAL DETECTORS MARKET, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 49 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 50 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 120 TABLE 51 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (HUNDRED UNITS) 121 TABLE 52 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 121 TABLE 53 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 122 TABLE 54 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 122 TABLE 55 US: KEY MACROINDICATORS 123 TABLE 56 US: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 123 TABLE 57 US: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 124 TABLE 58 US: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 124 TABLE 59 US: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 125 TABLE 60 CANADA: KEY MACROINDICATORS 126 TABLE 61 CANADA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 126 TABLE 62 CANADA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 127 TABLE 63 CANADA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127 TABLE 64 CANADA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 128 TABLE 65 EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 66 EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 130 TABLE 67 EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (HUNDRED UNITS) 130 TABLE 68 EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 131 TABLE 69 EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131 TABLE 70 EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 132 TABLE 71 GERMANY: KEY MACROINDICATORS 133 TABLE 72 GERMANY: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 133 TABLE 73 GERMANY: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 134 TABLE 74 GERMANY: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 134 TABLE 75 GERMANY: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 135 TABLE 76 UK: KEY MACROINDICATORS 136 TABLE 77 UK: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 136 TABLE 78 UK: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 137 TABLE 79 UK: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137 TABLE 80 UK: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 81 FRANCE: KEY MACROINDICATORS 138 TABLE 82 FRANCE: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 139 TABLE 83 FRANCE: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 139 TABLE 84 FRANCE: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 85 FRANCE: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 86 ITALY: KEY MACROINDICATORS 141 TABLE 87 ITALY: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 141 TABLE 88 ITALY: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 142 TABLE 89 ITALY: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 142 TABLE 90 ITALY: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 143 TABLE 91 SPAIN: KEY MACROINDICATORS 143 TABLE 92 SPAIN: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 144 TABLE 93 SPAIN: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 144 TABLE 94 SPAIN: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145 TABLE 95 SPAIN: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 96 REST OF EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 146 TABLE 97 REST OF EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 146 TABLE 98 REST OF EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 99 REST OF EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 100 ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 101 ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 150 TABLE 102 ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (HUNDRED UNITS) 151 TABLE 103 ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 151 TABLE 104 ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 152 TABLE 105 ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 152 TABLE 106 CHINA: KEY MACROINDICATORS 153 TABLE 107 CHINA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 153 TABLE 108 CHINA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 154 TABLE 109 CHINA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 154 TABLE 110 CHINA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 155 TABLE 111 JAPAN: KEY MACROINDICATORS 156 TABLE 112 JAPAN: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 156 TABLE 113 JAPAN: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 157 TABLE 114 JAPAN: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 115 JAPAN: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 116 INDIA: KEY MACROINDICATORS 159 TABLE 117 INDIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 159 TABLE 118 INDIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 160 TABLE 119 INDIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160 TABLE 120 INDIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 161 TABLE 121 AUSTRALIA: KEY MACROINDICATORS 161 TABLE 122 AUSTRALIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 162 TABLE 123 AUSTRALIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 162 TABLE 124 AUSTRALIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 125 AUSTRALIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 126 SOUTH KOREA: KEY MACROINDICATORS 164 TABLE 127 SOUTH KOREA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164 TABLE 128 SOUTH KOREA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 165 TABLE 129 SOUTH KOREA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165 TABLE 130 SOUTH KOREA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 131 REST OF ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 167 TABLE 132 REST OF ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 167 TABLE 133 REST OF ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 168 TABLE 134 REST OF ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 168 TABLE 135 REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 169 TABLE 136 REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (HUNDRED UNITS) 170 TABLE 137 REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 170 TABLE 138 REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171 TABLE 139 REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 140 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL METAL DETECTORS MARKET 172 TABLE 141 PHARMACEUTICAL METAL DETECTORS MARKET: DEGREE OF COMPETITION 176 TABLE 142 PHARMACEUTICAL METAL DETECTORS MARKET: REGION FOOTPRINT 180 TABLE 143 PHARMACEUTICAL METAL DETECTORS MARKET: PRODUCT FOOTPRINT 181 TABLE 144 PHARMACEUTICAL METAL DETECTORS MARKET: TECHNOLOGY FOOTPRINT 182 TABLE 145 PHARMACEUTICAL METAL DETECTORS MARKET: APPLICATION FOOTPRINT 183 TABLE 146 PHARMACEUTICAL METAL DETECTORS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 186 TABLE 147 PHARMACEUTICAL METAL DETECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 187 TABLE 148 PHARMACEUTICAL METAL DETECTORS MARKET: PRODUCT LAUNCHES, JANUARY 2022 - MAY 2025 191 TABLE 149 PHARMACEUTICAL METAL DETECTORS MARKET: DEALS, JANUARY 2022 - MAY 2025 192 TABLE 150 PHARMACEUTICAL METAL DETECTORS MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 192 TABLE 151 PHARMACEUTICAL METAL DETECTORS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 192 TABLE 152 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY OVERVIEW 193 TABLE 153 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS OFFERED 194 TABLE 154 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 197 TABLE 155 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 198 TABLE 156 ANRITSU CORPORATION: COMPANY OVERVIEW 200 TABLE 157 ANRITSU CORPORATION: PRODUCTS OFFERED 201 TABLE 158 ANRITSU CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 202 TABLE 159 MINEBEAMITSUMI INC.: COMPANY OVERVIEW 204 TABLE 160 MINEBEAMITSUMI INC.: PRODUCTS OFFERED 205 TABLE 161 MINEBEAMITSUMI INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 206 TABLE 162 ILLINOIS TOOL WORKS INC.: COMPANY OVERVIEW 207 TABLE 163 ILLINOIS TOOL WORKS INC.: PRODUCTS OFFERED 208 TABLE 164 ILLINOIS TOOL WORKS INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 209 TABLE 165 ERIEZ MANUFACTURING CO.: COMPANY OVERVIEW 210 TABLE 166 ERIEZ MANUFACTURING CO.: PRODUCTS OFFERED 210 TABLE 167 ERIEZ MANUFACTURING CO.: DEALS, JANUARY 2022–JUNE 2025 211 TABLE 168 ERIEZ MANUFACTURING CO.: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 211 TABLE 169 CEIA S.P.A.: COMPANY OVERVIEW 213 TABLE 170 CEIA S.P.A.: PRODUCTS OFFERED 213 TABLE 171 CEIA S.P.A.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 214 TABLE 172 CEIA S.P.A.: EXPANSIONS, JANUARY 2022–JUNE 2025 215 TABLE 173 FORTRESS TECHNOLOGY INC.: COMPANY OVERVIEW 216 TABLE 174 FORTRESS TECHNOLOGY INC.: PRODUCTS OFFERED 216 TABLE 175 FORTRESS TECHNOLOGY INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 217 TABLE 176 FORTRESS TECHNOLOGY INC.: DEALS, JANUARY 2022–JUNE 2025 217 TABLE 177 CASSEL MESSTECHNIK GMBH: COMPANY OVERVIEW 218 TABLE 178 CASSEL MESSTECHNIK GMBH: PRODUCTS OFFERED 218 TABLE 179 CASSEL MESSTECHNIK GMBH: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 219 TABLE 180 BUNTING: COMPANY OVERVIEW 220 TABLE 181 BUNTING: PRODUCTS OFFERED 220 TABLE 182 NIKKA DENSOK LIMITED: COMPANY OVERVIEW 221 TABLE 183 NIKKA DENSOK LIMITED: PRODUCTS OFFERED 221 TABLE 184 PRISMA INDUSTRIALE S.R.L.: COMPANY OVERVIEW 223 TABLE 185 PRISMA INDUSTRIALE S.R.L.: PRODUCTS OFFERED 223 TABLE 186 WIPOTEC GMBH: COMPANY OVERVIEW 224 TABLE 187 WIPOTEC GMBH: PRODUCTS OFFERED 224 TABLE 188 DONGGUAN COSO ELECTRONIC TECH CO., LTD.: COMPANY OVERVIEW 225 TABLE 189 DONGGUAN COSO ELECTRONIC TECH CO., LTD.: PRODUCTS OFFERED 225 TABLE 190 VINSYST TECHNOLOGIES: COMPANY OVERVIEW 226 TABLE 191 VINSYST TECHNOLOGIES: PRODUCTS OFFERED 226 FIGURE 1 PHARMACEUTICAL METAL DETECTORS MARKET SEGMENTATION & REGIONAL SCOPE 24 FIGURE 2 RESEARCH DESIGN 28 FIGURE 3 PRIMARY SOURCES 31 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 33 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 34 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: METTLER-TOLEDO INTERNATIONAL INC. 35 FIGURE 9 PHARMACEUTICAL METAL DETECTORS MARKET: SUPPLY-SIDE ANALYSIS (2024) 36 FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 37 FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38 FIGURE 12 TOP-DOWN APPROACH 39 FIGURE 13 DATA TRIANGULATION METHODOLOGY 40 FIGURE 14 PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 43 FIGURE 15 PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 44 FIGURE 16 PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 44 FIGURE 17 PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 45 FIGURE 18 PHARMACEUTICAL METAL DETECTORS MARKET: GEOGRAPHIC SNAPSHOT 46 FIGURE 19 GROWING NUMBER OF PRODUCT RECALLS DUE TO METAL CONTAMINATION TO DRIVE GROWTH IN PHARMACEUTICAL METAL DETECTORS MARKET 47 FIGURE 20 TABLET METAL DETECTORS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL METAL DETECTORS MARKET IN 2024 48 FIGURE 21 NORTH AMERICA TO REGISTER HIGHEST CAGR IN MARKET THROUGHOUT FORECAST PERIOD 49 FIGURE 22 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 50 FIGURE 23 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 51 FIGURE 24 PHARMACEUTICAL METAL DETECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53 FIGURE 25 PHARMACEUTICAL METAL DETECTORS MARKET: PORTER’S FIVE FORCES ANALYSIS 60 FIGURE 26 PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2015–MAY 2025) 69 FIGURE 27 TOP APPLICANT COUNTRIES/REGIONS FOR PHARMACEUTICAL METAL DETECTOR PATENTS (JANUARY 2015–MAY 2025) 70 FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 74 FIGURE 29 KEY BUYING CRITERIA FOR PHARMACEUTICAL METAL DETECTORS, BY END USER 74 FIGURE 30 PHARMACEUTICAL METAL DETECTORS MARKET: VALUE CHAIN ANALYSIS 78 FIGURE 31 PHARMACEUTICAL METAL DETECTORS MARKET: ECOSYSTEM ANALYSIS 79 FIGURE 32 PHARMACEUTICAL METAL DETECTORS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81 FIGURE 33 PHARMACEUTICAL METAL DETECTORS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024 81 FIGURE 34 PHARMACEUTICAL METAL DETECTORS MARKET: GEOGRAPHIC SNAPSHOT 117 FIGURE 35 NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET SNAPSHOT 119 FIGURE 36 ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET SNAPSHOT 149 FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL METAL DETECTORS MARKET (2022−2024) 174 FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL METAL DETECTORS MARKET (2024) 175 FIGURE 39 PHARMACEUTICAL METAL DETECTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 178 FIGURE 40 PHARMACEUTICAL METAL DETECTORS MARKET: COMPANY FOOTPRINT 179 FIGURE 41 PHARMACEUTICAL METAL DETECTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 185 FIGURE 42 PHARMACEUTICAL METAL DETECTORS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 188 FIGURE 43 R&D EXPENDITURE OF KEY PLAYERS IN PHARMACEUTICAL METAL DETECTORS MARKET, 2022−2024 189 FIGURE 44 EV/EBITDA OF KEY VENDORS 189 FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 190 FIGURE 46 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2024) 194 FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 198 FIGURE 48 ANRITSU CORPORATION: COMPANY SNAPSHOT (2024) 201 FIGURE 49 MINEBEAMITSUMI INC.: COMPANY SNAPSHOT (2024) 205 FIGURE 50 ILLINOIS TOOL WORKS INC.: COMPANY SNAPSHOT (2024) 208

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們